top of page

BioVenture Voices Episode 36: Sofinnova Invetments' Jim Healy

  • Mar 9
  • 1 min read

He discusses learnings from his decades in venture at Sofinnova Investments including 'products vs platform', therapeutics areas of interest, modalities, and how he utilizes board seats and thinks about management teams.




Chapters

Intro and early life – 0:39

MD / PhD at Stanford – 5:10

Intro to venture – 9:39

Joining Sofinnova – 13:32

Product vs platform – 20:55

Board seats – 26:00

Investment strategy – 30:08

Therapeutic areas – 39:42

Regulatory predictability – 43:03

Management teams – 46:07

AI – 50:59

Modalities – 53:54

Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter
  • LinkedIn
  • Facebook
  • TikTok
  • Instagram

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

bottom of page